In conjunction with previous findings, the present study indicated that ibudilast administration effectively blocked the pro-inflammatory response by downregulating the TLR4/NF-κB-mediated pathway and inhibiting NLRP3 inflammasome activation in an FA-induced AKI model. The gene discussed is TLR4; the disease is acute kidney injury.